Por favor, use este identificador para citar o enlazar este ítem:
https://doi.org/10.1021/acs.jmedchem.3c00586
Twittear
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Cutillas Aullo, Natalia | - |
dc.contributor.author | Ruiz López, José | - |
dc.contributor.author | Novohradsky, Vojtech | - |
dc.contributor.author | Marco Calero, Alicia | - |
dc.contributor.author | Markova, Lenka | - |
dc.contributor.author | Brabec, Viktor | - |
dc.contributor.other | Facultades, Departamentos, Servicios y Escuelas::Departamentos de la UMU::Química Inorgánica | - |
dc.date.accessioned | 2024-04-11T22:11:14Z | - |
dc.date.available | 2024-04-11T22:11:14Z | - |
dc.date.issued | 2023-06-06 | - |
dc.identifier.citation | Journal of Medicinal Chemistry 2023, 66, 9766−9783 | - |
dc.identifier.issn | Print: 0022-2623 | - |
dc.identifier.issn | Electronic: 1520-4804 | - |
dc.identifier.uri | http://hdl.handle.net/10201/140744 | - |
dc.description | ©2023. This manuscript version is made available under the CC-BY 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ This document is the Published, version of a Published Work that appeared in final form in Journal of Medicinal Chemistry. To access the final edited and published work see https://doi.org/10.1021/acs.jmedchem.3c00586 | - |
dc.description.abstract | Herein, we report a series of new octahedral iridium(III) complexes Ir1–Ir9 of the type [Ir(N^N^N)(C^N)Cl]PF6 (N^N^N = 4′-(p-tolyl)-2,2′:6′,2″-terpyridine; C^N = deprotonated 2-arylbenzimidazole backbone) to introduce new metal-based compounds for effective inhibition of metastatic processes in triple-negative breast cancer (TNBC). The results show that the structural modifications within the C^N scaffold strongly impact the antimetastatic properties of these complexes in TNBC cells. Furthermore, testing the antimetastatic effects of the investigated Ir complexes revealed that the highest antimetastatic activity in TNBC cells is exhibited by complex Ir1. This result was in contrast to the effects of the clinically used drug doxorubicin used in conventional chemotherapy of TNBC, which conversely promoted metastatic properties of TNBC cells. Thus, the latter result suggests that doxorubicin chemotherapy may increase the risk of metastasis of breast cancer cells, so the search for new drugs to treat breast cancer that would show better antitumor effects than doxorubicin is justified. | - |
dc.format | application/pdf | es_ES |
dc.format.extent | 18 | - |
dc.language | eng | es_ES |
dc.publisher | American Chemical Society | - |
dc.rights | info:eu-repo/semantics/openAccess | * |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights | Atribución 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Antineoplastic agents | es_ES |
dc.subject | Cancer | es_ES |
dc.subject | Cells | es_ES |
dc.subject | Genetics | es_ES |
dc.subject | Transition metals | - |
dc.title | Ir(III) Compounds Containing a Terdentate Ligand Are Potent Inhibitors of Proliferation and Effective Antimetastatic Agents in Aggressive Triple-Negative Breast Cancer Cells | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.relation.publisherversion | https://pubs.acs.org/doi/10.1021/acs.jmedchem.3c00586?ref=PDF | - |
dc.embargo.terms | Si | - |
dc.identifier.doi | https://doi.org/10.1021/acs.jmedchem.3c00586 | - |
Aparece en las colecciones: | Artículos: Química Inorgánica |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
novohradsk..3.pdf | 9,02 MB | Adobe PDF | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons